University of Cape Town
Cape Town, South Africa
Location status: Recruiting
NCT Number: NCT07032363
The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV and depression. The main questions it aims to answer are:
What proportion of patients start an evidence-based treatment for depression (reach)? What percentage of patients show clinical improvement in depression and what percentage attain viral undetectability within one year (effectiveness)?
Researchers will compare high and low reach clinics to further inform tailored implementation strategies for uptake and maintenance.
Clinics will be randomized into one of two study arms: core versus enhanced strategies. In both arms, core strategies will be utilized. Enhanced clinics will also receive more resource-intensive training.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Cape Town, South Africa
Location status: Recruiting
Objectives:
Our primary objective is to compare a core set to an enhanced set of implementation strategies for extending the reach of evidence-based treatments for depression to patients with uncontrolled HIV in South Africa (SA) HIV care settings. Using RE-AIM as the implementation outcome framework, the primary outcome is reach, defined as the percent of patients who start an evidence-based treatment for depression (i.e., CBT-AD and/or psychopharmacotherapy).
To further inform optimal implementation strategies, we will also examine possible moderators and mediators of implementation outcomes including the hypothesized mechanisms of the Implementation Research Logic Model (IRLM) (e.g., clinic level variables, self-efficacy, capacity for training, intervention delivery).
Our secondary objectives are effectiveness focused in order to assess differences in patient-level depression and HIV outcomes when using the enhanced versus the core set of strategies.
Study Procedures:
This is a cluster (clinic based), staged, randomized implementation trial, in 10 public primary HIV care clinics surrounding Cape Town, SA. We will compare a core and an enhanced set of implementation strategies. Because this is a type 3 hybrid implementation/effectiveness study, we are primarily examining implementation outcomes (i.e., reach). However, we will also collect information about whether the effectiveness of the interventions varies as a function of the implementation strategies used to support them. The primary "participants" in this trial are the 10 randomized clinics. In order to evaluate implementation and effectiveness outcomes, patient data will be extracted from clinic records. Research materials that we will extract will consist of 1) PHQ data to assess depression, 2) records relating to depression treatment (e.g., medications prescribed, psychosocial treatments received), 3) HIV viral load lab results 4) Demographic information, and 5) HIV treatment history (e.g. number of years living with HIV, other HIV history). Data will be abstracted from records at regular intervals for one year.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Clinics (the primary "participants"):
Inclusion criteria
for Patient-level Outcomes:
Although the unit of randomization is at the clinic level, the study will be looking at adult patient level data at each clinic. All patients engaged in care at one of the 10 primary care/HIV treatment clinics in the study will be included if they:
Exclusion criteria
-Children below the age of 18 will not be included in the proposed study for adults.
Time frame: 1 year
Proportion of patients who start an evidence-based treatment for depression out of patients identified with positive depression and a detectable viral load
Time frame: 1 year
Of those identified as having depression and detectable virus, the percentage of patients, after one year, who are considered depression treatment responders (categorized as a responder if they achieve significant reduction in symptoms on the PHQ or if they no longer meet clinical criteria for depression).
Time frame: 1 year
Of those identified with detectable virus and depression, the percentage of patients who attain an undetectable HIV RNA viral load across the two arms.
Contact information is provided by the study sponsor or research team.
University of Miami
Other
Implementing Depression and Adherence Treatment in South Africa HIV Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282173
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial DetailsNCT02620150
AIDS, Acquired Immunodeficiency Syndrome
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06389565
Acquired Immunodeficiency Syndrome, Behavior
Ibadan, Oyo State, Nigeria
View Trial DetailsNCT05849038
Acquired Immunodeficiency Syndrome, Anhedonia
Atlanta, Georgia, United States
View Trial Details